Agomelatine Increases BDNF Serum Levels in Depressed Patients in Correlation with the Improvement of Depressive Symptoms

The International Journal of Neuropsychopharmacology
Giovanni MartinottiMassimo Di Giannantonio

Abstract

Agomelatine modulates brain-derived neurotrophic factor expression via its interaction with melatonergic and serotonergic receptors and has shown promising results in terms of brain-derived neurotrophic factor increase in animal models. Twenty-seven patients were started on agomelatine (25mg/d). Venous blood was collected and brain-derived neurotrophic factor serum levels were measured at baseline and after 2 and 8 weeks along with a clinical assessment, including Hamilton Depression Rating Scale and Snaith-Hamilton Pleasure Scale. Brain-derived neurotrophic factor serum concentration increased after agomelatine treatment. Responders showed a significant increase in brain-derived neurotrophic factor levels after 2 weeks of agomelatine treatment; no difference was observed in nonresponders. Linear regression analysis showed that more prominent brain-derived neurotrophic factor level variation was associated with lower baseline BDNF levels and greater anhedonic features at baseline. Patients affected by depressive disorders showed an increase of brain-derived neurotrophic factor serum concentration after a 2-week treatment with agomelatine. The increase of brain-derived neurotrophic factor levels was found to be greater in patien...Continue Reading

References

Mar 26, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Mariusz PappElisabeth Mocaër
Aug 16, 2005·Progress in Neurobiology·Clive R Bramham, Elhoucine Messaoudi
Oct 20, 2006·Current Opinion in Pharmacology·Eero CastrénTomi Rantamäki
May 5, 2007·The International Journal of Neuropsychopharmacology·Jean Pierre Olié, Siegfried Kasper
Apr 11, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ugo FaragunaChiara Cirelli
Jul 3, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Amélie SoumierAnnie Daszuta
Sep 25, 2009·The International Journal of Neuropsychopharmacology·Eleni PaïzanisLaurence Lanfumey
Jan 30, 2010·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Raffaella MolteniMarco A Riva
Oct 1, 2010·The European Journal of Neuroscience·Nicola KuczewskiJean-Luc Gaiarsa
Dec 8, 2010·Biomarkers in Medicine·Antonio Lucio TeixeiraArthur Kummer
Oct 18, 2011·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Giorgio RacagniDaniela Tardito
Jun 23, 2012·Journal of Clinical Psychopharmacology·Giovanni MartinottiMassimo Di Giannantonio
Aug 8, 2012·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Daniela TarditoGiorgio Racagni
Nov 1, 2012·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Massimo Di Giannantonio, Giovanni Martinotti
Dec 24, 2013·Brain and Cognition·Francesco AngelucciCarlo Caltagirone
Mar 22, 2014·BMJ : British Medical Journal·David TaylorOlubanke Olofinjana

❮ Previous
Next ❯

Citations

Nov 12, 2016·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Andiara E FreitasAna Lúcia S Rodrigues
Sep 22, 2018·The International Journal of Neuroscience·Amal Chandra Mondal, Mahino Fatima
Jan 5, 2018·Clinical Practice and Epidemiology in Mental Health : CP & EMH·Bárbara C MonteiroSergio Machado
Mar 14, 2019·Current Pharmaceutical Design·Carmine TomasettiDomenico D Berardis
Jan 30, 2018·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·F Sh ShagiakhmetovI Yu Shamakina
Mar 12, 2020·Psychiatry Investigation·Giampaolo PernaDaniela Caldirola
Jun 23, 2020·Expert Opinion on Drug Discovery·George KonstantakopoulosPanayiota G Michalopoulou
Mar 18, 2017·Reviews in the Neurosciences·Raul Felipe Palma-ÁlvarezCarlos Roncero
Oct 27, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Feifei YangLijun Huo
Feb 16, 2019·Frontiers in Psychiatry·Bing CaoRoger S McIntyre
Jun 11, 2019·Frontiers in Psychiatry·Marianne DestoopGeert Dom
Oct 23, 2019·CNS Neuroscience & Therapeutics·Maria Chiara SpanoMassimo di Giannantonio
Dec 14, 2018·Pharmaceutics·Ewa KędzierskaJolanta Kotlińska
Oct 6, 2020·Climacteric : the Journal of the International Menopause Society·R ChenQ Yu
Nov 25, 2020·Journal of Molecular Neuroscience : MN·Tarapati RanaSimona Bungau
Mar 2, 2021·Frontiers in Behavioral Neuroscience·Beatrice ArosioIvan Aprahamian
Feb 18, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Xiangting LiDingfang Cai
Aug 24, 2021·Frontiers in Psychology·Ana Cecília de Menezes GalvãoNicole Leite Galvão-Coelho

❮ Previous
Next ❯

Methods Mentioned

BETA
contraception
ELISAs
ELISA

Software Mentioned

SPSS

Related Concepts

Related Feeds

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.